Immune to Cancer: The CRI Blog
-
CRI Funded Scientist
Hratch Baghdassarian, PhD
Hratch Baghdassarian, PhD, a bioinformatics expert, is developing computational tools to enhance CAR T-cell therapy’s effectiveness against… -
CRI Funded Scientist
Peter Wang, PhD
Peter Wang, PhD, is a postdoctoral research fellow at the Center for Systems Biology and the Center… -
CRI Funded Scientist
Rosa Vincent, PhD
Rosa Vincent, PhD, is a pioneering researcher developing novel therapies that combine engineered CAR T-cells and probiotic… -
CRI Funded Scientist
Aldo Ummarino, MD, PhD
Aldo Ummarino, MD, PhD, is an emerging leader in cancer research, developing innovative immunotherapies to combat pancreatic… -
CRI Funded Scientist
Harrison Sudholz, PhD
Harrison Sudholz, PhD, is investigating how the innate immune system—the body’s first line of defense—can be harnessed… -
CRI Funded Scientist
Parasvi Patel, PhD
Parasvi Patel, PhD, is working to improve treatments for colorectal cancer (CRC), a disease increasingly affecting younger… -
CRI Funded Scientist
Kat Mueller, PhD
Kat Mueller, PhD, is investigating the molecular mechanisms that determine CAR T-cell persistence—why some engineered immune cells… -
CRI Funded Scientist
Anukriti Mathur, PhD
Anukriti Mathur, PhD, is a postdoctoral fellow at the University of Massachusetts Chan Medical School, where she… -
CRI Funded Scientist
Mingeum Jeong, PhD
Mingeum Jeong, PhD, is pioneering research to improve treatments for solid tumors, which account for 90% of…

Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.